Dear Colleagues,

We are pleased to share the peer-reviewed highlights of Digestive Disease Week (DDW) 2015, held in Washington, DC, from May 16 to 19, 2015.

MD Conference Express_® provides timely, peer-reviewed highlights of high-impact presentations from the live conference, long before they are published in the academic literature, and it is a trusted education resource. The articles selected for this issue underwent a rigorous 5-step peer-review process to ensure their accuracy and provide a reliable interim information source prior to the research being vetted by the standard journal peer-review process.

The articles in this issue of MD Conference Express represent the most compelling topics of relevance to a broad array of practitioners and have the potential to influence clinical practice.

Among the clinical trial highlights presented at DDW was the finding that a monoclonal antibody improved remission rates and reduced symptoms in patients with ulcerative colitis in the TURANDOT study. The ALLY-2 study showed that combination treatment with daclatasvir and sofosbuvir safely and effectively treated patients coinfected with HIV and hepatitis C virus and did not compromise the ongoing HIV treatment.

The featured articles provide a review of management of alcoholic liver disease and the noninvasive assessment of fibrosis.

We hope that you find the information and practical perspectives in this issue of MD Conference Express helpful in integrating this new information into your clinical practice. For more information, please visit mdce.sagepub.com.